Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Helius Medical Technologies Inc (HSDT)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 179,325
  • Shares Outstanding, K 23,383
  • Annual Sales, $ 0 K
  • Annual Income, $ -28,020 K
  • 36-Month Beta 0.42
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/17
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year N/A
  • Growth Rate Est. (year over year) unch

Price Performance

See More
Period Period Low Period High Performance
1-Month
6.72 +12.65%
on 01/25/19
8.35 -9.34%
on 01/22/19
-0.76 (-9.12%)
since 01/18/19
3-Month
6.72 +12.65%
on 01/25/19
10.67 -29.05%
on 12/10/18
-0.43 (-5.37%)
since 11/19/18
52-Week
6.72 +12.65%
on 01/25/19
13.20 -42.65%
on 06/18/18
-3.73 (-32.99%)
since 02/16/18

Most Recent Stories

More News
HELIUS INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Helius Medical Technologies, Inc. To Contact The Firm

NEW YORK, NY / ACCESSWIRE / February 14, 2019 / Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Helius Medical Technologies, Inc. ("Helius" or the...

HSDT : 7.57 (-1.30%)
Uptick Newswire Hosts Helius Medical Technologies, Inc. on the Stock Day Podcast to Discuss the Company's Clearance in Canada and Expansion into The United States and Europe

Phoenix, Feb. 11th, 2019 (GLOBE NEWSWIRE) -- Uptick Newswire Stock Day Podcast welcomed Helius Medical Technologies, Inc. (HSDT) (HSM.TO) (the "Company"), a neurotech company focused on neurological wellness....

HSM.TO : 9.90 (-1.79%)
HSDT : 7.57 (-1.30%)
ONGOING INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Helius Medical Technologies, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Helius Medical Technologies, Inc. ("Helius" or "the Company") (NASDAQ:...

HSDT : 7.57 (-1.30%)
Investor Alert: Kaplan Fox Investigates Helius Medical Technologies, Inc.

Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating claims on behalf of investors of Helius Medical Technologiues, Inc. ("Helius" or the "Company") (Nasdaq: HSDT).

HSDT : 7.57 (-1.30%)
Bragar Eagel & Squire, P.C. is Investigating Helius Medical Technologies, Inc. (HSDT) on Behalf of Stockholders and Encourages HSDT Investors to Contact the Firm

Bragar Eagel & Squire, P.C. is investigating potential claims against Helius Medical Technologies, Inc. (NASDAQ: HSDT). Our investigation concerns whether Helius has violated the federal securities laws...

HSDT : 7.57 (-1.30%)
Helius Medical Technologies to Release Fourth Quarter and Fiscal Year 2018 Financial Results on March 14, 2019

Helius Medical Technologies, Inc. (NASDAQ:HSDT) (TSX:HSM) ("Helius" or the "Company"), a neurotech company focused on neurological wellness, today announced that fourth quarter and fiscal year 2018 financial...

HSM.TO : 9.90 (-1.79%)
HSDT : 7.57 (-1.30%)
SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Helius Medical Technologies, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / January 28, 2019 / , a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Helius Medical Technologies, Inc....

HSDT : 7.57 (-1.30%)
HELIUS INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Helius Medical Technologies, Inc. To Contact The Firm

Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Helius Medical Technologies, Inc. ("Helius" or the "Company") (NASDAQ:HSDT).

HSDT : 7.57 (-1.30%)
SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Helius Medical Technologies, Inc. (HSDT)

Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Helius Medical Technologies, Inc. ("Helius" or the "Company") (NASDAQ: HSDT). Such...

HSDT : 7.57 (-1.30%)
ONGOING INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Helius Medical Technologies, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Helius Medical Technologies, Inc. ("Helius" or "the Company") (NASDAQ:...

HSDT : 7.57 (-1.30%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 16% Sell with a Weakest short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators fully support a continuation of the trend.

See More Share

Trade HSDT with:

Business Summary

Helius Medical Technologies Inc. is a specialty medical device company. It is focused on the development and regulatory approval of its non-invasive neurostimulation device called PoNS. The Company is nearing clinical trials for balance disorders in TBI patients and for the treatment of MS. Helius Medical...

See More

Key Turning Points

2nd Resistance Point 8.00
1st Resistance Point 7.78
Last Price 7.57
1st Support Level 7.42
2nd Support Level 7.28

See More

52-Week High 13.20
Fibonacci 61.8% 10.72
Fibonacci 50% 9.96
Fibonacci 38.2% 9.20
Last Price 7.57
52-Week Low 6.72

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar